跳至主要内容
临床试验/EUCTR2008-006903-22-NL
EUCTR2008-006903-22-NL进行中(未招募)不适用

arrow band UV-B phototherapy and fluticasone proprionate versus narrow band UV-B phototherapy and placebo for the treatment of active vitiligo: a randomized double blind controlled trial - UVBVIT

Academic Medical Center0 个研究点开始时间: 2008年12月9日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • i.Patients with active vitiligo, eligible for NB-UVB phototherapy;
  • ii.Subjects attending the outpatient department of the SNIP;
  • iii.Adult patients: = 18 years;
  • iv.Subject is willing and able to give written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • v.With a personal or a family history of skin cancer (non-melanoma skin cancer: first degree family members, melanoma: any family member)
  • vi.With a personal history of photosensitivity and/or phototoxicity disorders
  • vii.With skin type I (according to Fitzpatrick classification I-VI)
  • viii.Who are pregnant
  • ix.Who are taking medications known to cause photosensitivity and/or phototoxicity and chronic or very frequent use of any medication that can influence the UVB response (eg. tetracycline, retinoids, sulfonamids, psoralens, NSAID’s)
  • x.With other skin diseases that would impair evaluation of repigmentation, such as psoriasis and eczema.
  • xi. Who are not able to have 2 times weekly NB-UVB phototherapy
  • xii. With local immunosuppressive treatment or 6 weeks prior to enrolment. For these patients a washout period of 6 weeks will be required.

研究者

发起方
Academic Medical Center

相似试验